Choroideremia (CHM) is a genetic disorder, meaning it is caused by changes, or mutations, in a person's DNA. Specifically, it is an X-linked recessive inherited retinal disease. Understanding the genetic basis and inheritance pattern of choroideremia is essential for accurate diagnosis, genetic counseling, and family planning.
The condition is caused by mutations in the CHM gene, which is located on the X chromosome. This gene provides the instructions for making a protein called Rab escort protein-1 (REP-1). The REP-1 protein plays a critical role in the intracellular transport of materials within the cells of the retina. When the CHM gene is mutated, the REP-1 protein is either absent or non-functional. This disruption leads to the gradual death of cells in the choroid, retinal pigment epithelium, and photoreceptors, ultimately resulting in the progressive vision loss characteristic of choroideremia.
Because the CHM gene is located on the X chromosome, the disease affects males and females differently. Males have one X chromosome and one Y chromosome (XY), while females have two X chromosomes (XX). If a male inherits an X chromosome with the mutated CHM gene, he will develop choroideremia because he does not have a second, healthy copy of the gene to compensate. Consequently, the disease primarily affects males.
Females who inherit one mutated CHM gene and one normal CHM gene are considered carriers. In most cases, the healthy gene produces enough REP-1 protein to maintain normal retinal function, and carriers typically do not experience severe vision loss. However, some female carriers may exhibit mild symptoms, such as night blindness or subtle changes in the retina that can be detected during a comprehensive eye exam.
The inheritance pattern has specific implications for family planning. An affected male cannot pass the mutated gene to his sons, as he only passes his Y chromosome to them. However, he will pass the mutated X chromosome to all of his daughters, making them obligate carriers. A female carrier has a 50% chance of passing the mutated gene to each of her children. If she passes it to a son, he will develop choroideremia; if she passes it to a daughter, the daughter will be a carrier.
Genetic testing is a vital tool for confirming a diagnosis of choroideremia and identifying the specific mutation involved. This information is not only crucial for the patient but also for family members who may wish to know their carrier status or risk of developing the disease. Patients and their families are strongly encouraged to consult with a genetic counselor or their healthcare provider to fully understand the implications of the genetic diagnosis and to explore available support and resources.